THIOCTIC ACID
1,2-Dithiolane-3-pentanoic acid, (+/-)-
THIOCTIC ACID은(는) EU CosIng 목록에 등재되어 있지만, 이 페이지에는 아직 직접 연결된 부속서 기록이 없습니다.
시장별 규제 근거
이 매트릭스는 검증된 원료 규칙과 매핑은 되었지만 아직 가져오지 않은 출처를 구분합니다. 가져온 규칙이 없다는 것이 해당 원료가 허용된다는 의미는 아닙니다.
모든 열을 보려면 가로로 스와이프하거나 스크롤하세요.
| 시장 | 근거 상태 | 기록 | 출처 언어 |
|---|---|---|---|
| European Union | 출처 매핑됨 Inventory entry; no linked annex rule | 0 | English and EU languages |
| Great Britain | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English |
| Canada | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English and French |
| New Zealand | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English |
| ASEAN | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English and national languages |
| China | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | Chinese with selected English material |
| Japan | 근거 연결됨 Restricted 이 근거 열기 | 1 | Japanese; official English translation available |
| South Korea | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | Korean with some English names |
| United States | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English |
| Australia | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English |
| Brazil | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | Portuguese with INCI crosswalks |
| India | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | English and Hindi |
| Saudi Arabia | 출처 매핑됨 Official source mapped; ingredient rule not imported | 0 | Arabic and English |
THIOCTIC ACID의 목록 세부 정보
INCI 명칭
THIOCTIC ACID
INN 명칭
Thioctic acid [JAN]
설명
1,2-Dithiolane-3-pentanoic acid, (+/-)-
THIOCTIC ACID의 부속서 기록
주요 데이터
- ANTIOXIDANT
Inhibiting reactions promoted by oxygen, thus avoiding oxidation and rancidity.
화학적 정체 및 특성

alpha Lipoic acid
Lipoic acid is a heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. It has a role as a geroprotector and a fundamental metabolite. It is a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a lipoate. — ChEBI
- IUPAC 명칭
- 5-(dithiolan-3-yl)pentanoic acid
- 분자식
- C8H14O2S2
- 분자량
- 206.3 g/mol
- 정확한 질량
- 206.04352203 Da
- XLogP3
- 1.7
- 위상 극성 표면적
- 87.9 Ų
- 수소 결합 공여체
- 1
- 수소 결합 수용체
- 4
- 공유결합 단위
- 1
- 정의된 입체중심
- 0
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
- ChEBI:CHEBI:16494
- ChEMBL:CHEMBL33864
- EPA DTXSID:DTXSID7025508
- PubMed:22654724
- PubMed:22448096
- PubMed:22384101
- PubMed:22374556
- PubMed:22363901
- PubMed:22272085
- PubMed:22242957
- PubMed:22163871
- PubMed:22163517
- PubMed:22146387
- PubMed:22125679
- PubMed:22125537
추가 과학 데이터베이스의 근거
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Forms yellowish flakes 출처: Hazardous Substances Data Bank (HSDB)
- Dissociation Constants: pKa = 5.10 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: 47.5-48 °C 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Yellow powder; solubility in ethanol: 50 mg/mL /Synthetic, oxidized form/ 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in methanol, ethanol, diethyl ether and chloroform 출처: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 출처: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (28 of 430) of reports. 출처: European Chemicals Agency (ECHA)
- Signal: Warning 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (48.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (46.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (47%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (46.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 430 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 28 of 430 reports by companies.; There are 14 notifications provided by 402 of 430 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 42.3% (52 of 123) of reports. 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (57.7%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (31.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (31.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H412 (19.5%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 123 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 52 of 123 reports by companies.; There are 7 notifications provided by 71 of 123 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre 출처: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: ALA is generally considered a safe drug. A daily dose of 200 mg/day to 2400 mg/day of ALA is deemed safe without significant adverse effects. However, there is no reported safe dose in children.; A notable case in literature demonstrated status epilepticus (SE) that subsided within a few days. The seizures were treated per normal standards for SE.; In the last 2 decades, there have been few reported cases of ALA toxicity in humans. Most of these cases occur in children and are treatable. Though there is no established lethal dosage of ALA for humans, studies have shown that a high dose of 121 mg/kg body weight/day was associated with alterations in liver enzymes and liver function. Therefore, there are potentially harmful adverse effects from overdosing on ALA, and more studies are necessary to determine the toxicity. 출처: StatPearls
- Toxicity Summary: (R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as 출처: Toxin and Toxin Target Database (T3DB)
- Uses: Nutrition, biochemical research /Thioctic acid, dl-form/ 출처: Hazardous Substances Data Bank (HSDB)
- Uses: THERAPEUTIC CATEGORY: Treatment of liver disease; antidote to poisonous mushrooms (Amanita species). 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >7500; Consumption (g per capita; approx.) in Germany (2009): 0.0916; Calculated removal (%): 96.4 출처: NORMAN Suspect List Exchange
- Uses: For nutritional supplementation, also for treating dietary shortage or imbalance. 출처: Toxin and Toxin Target Database (T3DB)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.
공식 EU 원료 명칭 근거
이 원료 명칭은 공식 2025 EU 일반 원료 명칭 용어집과 정확히 일치합니다.
관련 목록 근거
처방 기능이 겹치는 원료
추가 공식 및 과학 출처
이 정체를 확인할 외부 데이터베이스 11개
각 링크는 해당 출처에서 이 정체를 검색합니다. 각 출처의 성격과 법적 비중
CosIng 목록에서 THIOCTIC ACID이(가) 나타나는 방식
CosIng 목록은 THIOCTIC ACID을(를) 화장품 원료로 나열하며, 이 페이지는 이를 부속서 기록 0건과 연결합니다. 목록 항목은 명칭과 식별자를 담고 있으며, 부속서 기록은 해당 물질이 EU 화장품 법령에서 사용금지, 사용제한 또는 허용 목록(포지티브 리스트)에 있는 위치를 보여 줍니다.
THIOCTIC ACID은(는) 공식 데이터에서 화장품 기능 1개로도 태그되어 있습니다. 기능 표시는 의도된 용도를 설명하지만, 처방 또는 표시 작업 전에 연결된 부속서 기록에 대한 규제 검토를 대체하지 않습니다.